SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...
In a report released on November 14, David Evans from Kepler Capital maintained a Buy rating on Merck KGaA (0O14 – Research Report), ...